Fig. 1
From: Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma
IRF4 antisense oligonucleotides decreased proliferation of adult T-cell leukemia. a Resazurin proliferation assay of cells treated for 7 days with 20 μM IRF4#1 normalized to cells treated with Control ASO. b Resazurin proliferation assay at 7 days post-treatment. c Resazurin proliferation time course of cells treated with 5 μM ASOs. d 2 days post-treatment with 10 μM ASOs. e ATL-ED cells 4 days post treatment with varying doses of IRF4#1 ASO. Bands were quantified using BioRad software and presented values are normalized to actin. f 3 days post-treatment with 20 μM IRF4#1 ASO. g 3 days post-treatment with 10 μM ASOs